propranolol has been researched along with Neurally Mediated Faint in 18 studies
Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In patients with neurocardiogenic syncope, head-up tilt often evokes acute loss of consciousness accompanied by vasodilatation, increased plasma adrenaline and systemic hypotension." | 2.72 | Failure of propranolol to prevent tilt-evoked systemic vasodilatation, adrenaline release and neurocardiogenic syncope. ( Eldadah, BA; Goldstein, DS; Holmes, CS; Moak, JP; Pechnik, SL; Saleem, AM, 2006) |
| "We describe a patient with a history of neurocardiogenic syncopes who had a positive headup tilt test that resulted in an lasting asystole lasting 34 seconds." | 1.33 | Prolonged asystole provoked by head-up tilt testing. ( Frühwirth, M; Moser, M; Pezawas, T; Rüdiger, HW; Saul, P; Schmidinger, H; Winker, R, 2006) |
| "Propranolol was considered effective when the result of the second (on drug) TT was negative or the time to syncope occurrence was longer than during baseline TT." | 1.32 | Value of propranolol-induced heart rate and blood pressure changes in predicting results of tilt testing. ( Cholewa, M; Dłuzniewska, E; Gielerak, G; Kozłowski, D; Roszczyk, A, 2003) |
| "When vasovagal syncope was induced (positive response), the HUT was repeated to examine the test reproducibility." | 1.30 | Long-term effects of pharmacological therapy for vasovagal syncope on the basis of reproducibility during head-up tilt testing. ( Baba, T; Chiyoda, K; Katagiri, T; Kikushima, S; Kobayashi, Y; Miyata, A; Nakagawa, H; Obara, C; Shinohara, M; Tanno, K; Zinbo, Y, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (16.67) | 18.2507 |
| 2000's | 15 (83.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kapoor, JR | 1 |
| Flevari, P | 2 |
| Livanis, EG | 2 |
| Theodorakis, GN | 2 |
| Zarvalis, E | 1 |
| Mesiskli, T | 1 |
| Kremastinos, DT | 2 |
| Phillips, J | 1 |
| Krist, A | 1 |
| Alegria, JR | 1 |
| Gersh, BJ | 1 |
| Scott, CG | 1 |
| Hodge, DO | 1 |
| Hammill, SC | 1 |
| Shen, WK | 1 |
| Gielerak, G | 3 |
| Kozłowski, D | 1 |
| Dłuzniewska, E | 2 |
| Roszczyk, A | 1 |
| Cholewa, M | 3 |
| Makowski, K | 2 |
| Stec, A | 1 |
| Thaman, R | 1 |
| Elliott, PM | 1 |
| Shah, JS | 1 |
| Mist, B | 1 |
| Williams, L | 1 |
| Murphy, RT | 1 |
| McKenna, WJ | 1 |
| Frenneaux, MP | 1 |
| Winker, R | 1 |
| Frühwirth, M | 1 |
| Saul, P | 1 |
| Rüdiger, HW | 1 |
| Pezawas, T | 1 |
| Schmidinger, H | 1 |
| Moser, M | 1 |
| Leftheriotis, D | 1 |
| Karabela, G | 1 |
| Aggelopoulou, N | 1 |
| Eldadah, BA | 1 |
| Pechnik, SL | 1 |
| Holmes, CS | 1 |
| Moak, JP | 1 |
| Saleem, AM | 1 |
| Goldstein, DS | 1 |
| Mathias, CJ | 1 |
| Amaki, M | 1 |
| Kamide, K | 1 |
| Takiuchi, S | 1 |
| Niizuma, S | 1 |
| Horio, T | 1 |
| Kawano, Y | 1 |
| Saito, F | 1 |
| Imai, S | 1 |
| Tanaka, N | 1 |
| Tanaka, H | 1 |
| Suzuki, K | 1 |
| Takase, H | 1 |
| Aoyama, H | 1 |
| Matsudaira, K | 1 |
| Ebuchi, T | 1 |
| Akamine, Y | 1 |
| Takahashi, N | 1 |
| Sugino, K | 1 |
| Kanmatsuse, K | 1 |
| Yagi, H | 1 |
| Kushiro, T | 1 |
| Abe, H | 1 |
| Kohshi, K | 1 |
| Kuroiwa, A | 1 |
| Nakagawa, H | 1 |
| Kobayashi, Y | 1 |
| Kikushima, S | 1 |
| Shinohara, M | 1 |
| Obara, C | 1 |
| Zinbo, Y | 1 |
| Chiyoda, K | 1 |
| Miyata, A | 1 |
| Tanno, K | 1 |
| Baba, T | 1 |
| Katagiri, T | 1 |
| Di Girolamo, E | 1 |
| Di Iorio, C | 1 |
| Sabatini, P | 1 |
| Leonzio, L | 1 |
| Barsotti, A | 1 |
| Bisharat, N | 1 |
| Paz, E | 1 |
| Klimov, A | 1 |
| Friedberg, N | 1 |
| Elias, M | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Effects of Spinal Cord Stimulation on Autonomic Function in People With Spinal Cord Injury[NCT03924388] | 46 participants (Anticipated) | Interventional | 2020-02-01 | Not yet recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
6 trials available for propranolol and Neurally Mediated Faint
| Article | Year |
|---|---|
Vasovagal syncope: a prospective, randomized, crossover evaluation of the effect of propranolol, nadolol and placebo on syncope recurrence and patients' well-being.
Topics: Adrenergic beta-Antagonists; Adult; Cross-Over Studies; Female; Follow-Up Studies; Humans; Male; Nad | 2002 |
Beta-blockers no better than placebo in the treatment of vasovagal syncope.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Cross-Over Studies; Dose-Response Relationship, Drug; Drug | 2002 |
Reversal of inappropriate peripheral vascular responses in hypertrophic cardiomyopathy.
Topics: Adrenergic beta-Antagonists; Adult; Blood Pressure; Cardiomyopathy, Hypertrophic, Familial; Clonidin | 2005 |
Fluoxetine vs. propranolol in the treatment of vasovagal syncope: a prospective, randomized, placebo-controlled study.
Topics: Adrenergic beta-Antagonists; Adult; Attitude to Health; Double-Blind Method; Female; Fluoxetine; Hum | 2006 |
Failure of propranolol to prevent tilt-evoked systemic vasodilatation, adrenaline release and neurocardiogenic syncope.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Anthropometry; Cross-Over Studies; Double-Blind Meth | 2006 |
[Evaluation of the effects of diverse therapeutic treatments versus no treatment of patients with neurocardiogenic syncope].
Topics: Adolescent; Adult; Aged; Etilefrine; Evaluation Studies as Topic; Female; Humans; Male; Middle Aged; | 1998 |
12 other studies available for propranolol and Neurally Mediated Faint
| Article | Year |
|---|---|
Predicting the effectiveness of beta-blocker therapy in vasovagal syncope.
Topics: Adrenergic beta-Antagonists; Humans; Propanolamines; Propranolol; Syncope, Vasovagal; Tilt-Table Tes | 2008 |
Comparison of frequency of recurrent syncope after beta-blocker therapy versus conservative management for patients with vasovagal syncope.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Comorbidity; Female; Humans; Male; Metoprolol; M | 2003 |
Value of propranolol-induced heart rate and blood pressure changes in predicting results of tilt testing.
Topics: Adrenergic beta-Antagonists; Adult; Blood Flow Velocity; Blood Pressure; Dose-Response Relationship, | 2003 |
The usefulness of tilt testing with an intravenous beta-blocker in assessing the efficacy of long-term therapy in patients with vasovagal syncope.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Adult; Female; Humans; Infusions, Intravenous; Ma | 2003 |
Prognostic value of head-up tilt test with intravenous beta-blocker administration in assessing the efficacy of therapy in patients with vasovagal syncope.
Topics: Adrenergic beta-Antagonists; Adult; Chi-Square Distribution; Female; Humans; Infusions, Intravenous; | 2005 |
Prolonged asystole provoked by head-up tilt testing.
Topics: Adult; Antihypertensive Agents; Heart Arrest; Humans; Propranolol; Syncope, Vasovagal; Tilt-Table Te | 2006 |
beta-adrenergic receptor blockers and the treatment of vasovagal syncope: more nails in the coffin!
Topics: Adrenergic beta-Antagonists; Humans; Propranolol; Randomized Controlled Trials as Topic; Research De | 2006 |
A case of neurally mediated syncope induced by laughter successfully treated with combination of propranolol and midodrine.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Aged; Drug Therapy, Combination; Electrocard | 2007 |
Basic autonomic nervous function in patients with neurocardiogenic syncope.
Topics: Adolescent; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adrenergic beta-Agonists; Adren | 2007 |
Possible involvement of cerebral hypoperfusion as trigger of neurally-mediated vasovagal syncope.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Adult; Cerebrovascular Circulation; Cerebrovascul | 1998 |
Long-term effects of pharmacological therapy for vasovagal syncope on the basis of reproducibility during head-up tilt testing.
Topics: Administration, Oral; Adult; Disopyramide; Female; Follow-Up Studies; Head-Down Tilt; Humans; Inject | 1998 |
Cerebral syncope in a patient with spinal cord injury.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Cerebrovascular Circulation; Fatal Outcome; Fe | 2002 |